CD79A and influenza: The highest salivary IgA concentrations were found in the groups receiving the adjuvanted vaccine and the influenza-specific IgA concentrations were significantly higher in the intranasal c-di-GMP adjuvanted (IN+) and sublingual c-di-GMP adjuvanted (SL+) groups than in all other groups (p<0.001).